Sotyktu/Deucra Abstract Titles at ACR2022 10-14Nov2022 | BMY Message Board Posts


Bristol-Myers Squibb Co.

  BMY website

BMY   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board
Msg  10305 of 10562  at  9/21/2022 11:49:06 AM  by

Baltasar


 In response to msg 10304 by  grafzeppelin
view thread

Re: Sotyktu/Deucra Abstract Titles at ACR2022 10-14Nov2022

 makes sense and I think the sales force will be able to differentiate on the starting dose alone:  deucra is so well tolerated that you can start with the maintenance dose as dose one whereas apr takes at least a week to be titrated up given it's GI intolerance.  


     e-mail to a friend      printer-friendly     add to library      
|  
Recs: 8  
   Views: 0 []
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board




Financial Market Data provided by
.
Loading...